Dublin Mid-West TD Emer Higgins has welcomed a €36m investment by Takeda into their plant in Grange Castle.
The Japanese pharma group, Takeda, began operations in 2007 and this latest investment will support the expansion of the company’s production facility.
The commercial scale cell therapy production facility is the first of its kind in Ireland.
Following the expansion, the team at Grange Castle will play an important role in supplying European, US and Canadian markets with a cell therapy treatment option for patients.
It will create approximately 100 new jobs in Grange Castle over the next three years.
“Grange Castle is a thriving business park and it’s great to see operations like Takeda’s expand and succeed here,” explained Deputy Emer Higgins.
“100 new jobs are being created by Takeda in this latest expansion.
“Takeda provides end-to-end research and development capabilities, and this new investment will accelerate their efforts to develop next-generation cell therapies in areas like oncology.
“It’s really encouraging to see investment from multinational corporations as it’s a vote of confidence in what we, as a County, can offer to businesses.
“Job creation is good news for both our local area and our local economy, and innovations like cell therapy are good news for modern medicine.”